A Study in Subjects With Perennial Allergic Rhinitis
NCT00210015
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
630
Enrollment
INDUSTRY
Sponsor class
Conditions
Perennial Allergic Rhinitis
Interventions
DRUG:
INS37217 Nasal Spray
Sponsor
Merck Sharp & Dohme LLC